None ...

Adobe's long-time CEO will step down as soon as he finds a replacement, but the company desperately needs a strong direction ...

REGENXBIO (NASDAQ:RGNX) outlined a slate of near-term clinical catalysts and provided financial updates during its fourth-quarter and year-end 2025 earnings call, emphasizing what management described ...

Canva’s new AI-powered tool can intelligently detect and split up elements of a flat image – could this revolutionize ...

Photoshop remains supreme among editing software for photos, graphics and videos. Here's how and why to use Photoshop for ...

Good afternoon, everyone, and welcome to SentinelOne's earnings call for the fiscal year ended January 31, 2026. With us today are Tomer Weingarten, CEO; and Barry Padgett, Interim CFO.

Highly comparable biodistribution profiles of Radio-DARPin candidates labeled with imaging isotopes 177Lu or 203Pb allows for rapid expansion of pipeline with multiple therapeutic isotopes ...

Initiated US Phase 1/2a study of DLL3-targeting 212Pb-based Radio-DARPin candidate MP0712 for SCLC and other neuroendocrine cancers, co-developed ...

Affinity update adds Light UI, Convert to Curves, and Live Tone Blend Groups for faster vector, photo, and compositing workflows.

RegenXBio reported that dosing is complete in the AFFINITY pivotal Duchenne trial, with robust enrollment in the confirmatory study and encouraging Phase 1/2 data. At 18 months, treated boys showed a ...